Sat, Aug 2, 2014, 12:47 AM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Affymax, Inc. (AFFY) Message Board

fashionbondage 2 posts  |  Last Activity: May 14, 2014 6:18 PM Member since: Jan 23, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • In April 2014, the Company completed enrollment in our Phase I/II clinical trial in chronic spinal cord injury. The multi-national, open-label, Phase I/II trial is evaluating both safety and preliminary efficacy of our proprietary HuCNS-SC product candidate as a treatment for chronic spinal cord injury. The trial enrolled twelve subjects with chest-level injury to the spinal cord: seven patients with complete paralysis, no motor or sensory function below the point of injury, classified as complete (AIS A), according to the American Spinal Injury Association Impairment Scale, and five patients with no motor function and limited sensory function below the point of injury classified as incomplete (AIS B). Dr. Armin Curt, the principal investigator for the trial at Balgrist Hospital, Zurich will present a clinical update on this study on Saturday May 17, at the Annual Meeting of the American Spinal Injury Association, to be held in San Antonio, Texas.

    Sentiment: Buy

  • fashionbondage by fashionbondage May 6, 2014 10:35 AM Flag

    Today is the DAY nihd tart ing to go up, will see $1 by Friday.

0.100.00(0.00%)Aug 1 3:55 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Berkshire Hathaway Inc.
NYSEFri, Aug 1, 2014 4:02 PM EDT
Tesla Motors, Inc.
NasdaqGSFri, Aug 1, 2014 4:00 PM EDT